
Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Westlake BioPartners is a life science venture capital firm established to bolster the biotech ecosystem in Los Angeles. Founded by a team of experienced professionals, the firm focuses on supporting entrepreneurs from the ideation stage through to clinical and commercial impact. Westlake BioPartners connects innovators with essential capital and community resources to address significant patient needs.
Currently, the firm manages a concentrated portfolio of seven companies, allowing for personalized attention and strategic guidance. Westlake BioPartners emphasizes a hands-on approach, ensuring that each portfolio company receives the support necessary to navigate the complexities of the biotech industry. The firm operates from its office located in Westlake Village, California, and is committed to fostering growth in the life sciences sector.
Westlake BioPartners invests primarily in life sciences, with a specific emphasis on the development of new medicines. The firm targets early-stage investments, including pre-seed, seed, and Series A rounds, focusing on biotech and healthcare sectors. Their investment strategy is characterized by a concentrated portfolio, which enables them to provide in-depth support and resources to each company.
The firm adopts a people-first approach, working closely with entrepreneurs to guide them through various stages of company formation and growth. Westlake BioPartners seeks founders who are passionate about their innovations and are committed to addressing significant patient needs. They prioritize investments that demonstrate potential for clinical and commercial impact, ensuring that their portfolio aligns with their mission of advancing healthcare solutions.
Westlake BioPartners has a diverse portfolio of seven notable companies in the biotech sector:
This portfolio reflects Westlake BioPartners' commitment to supporting innovative solutions in the life sciences, particularly in areas with significant unmet medical needs.
David Allison, PhD: Managing Director with extensive experience in life sciences and venture capital. He has a strong background in supporting biotech startups through various stages of development.
Mira Chaurushiya, PhD: Managing Director who specializes in guiding early-stage biotech companies. She has a proven track record in the life sciences sector.
Beth Seidenberg, MD: Founding Managing Director with a wealth of experience in healthcare investments and a strong network in the biotech community.
Armando Alvarez, CPA: Finance Manager responsible for overseeing financial operations and ensuring compliance within the firm.
Eric Kaufman: Strategic Advisor with a focus on enhancing the firm's investment strategies and portfolio management.
Jennifer Kercher, JD: General Counsel providing legal guidance and support for the firm's investment activities.
Kelli McKeirnan: Director of Administration managing the firm's administrative functions and operations.
Founders interested in pitching to Westlake BioPartners should use the contact form available on their website. It is important to include a comprehensive pitch deck that outlines the business model, market opportunity, and team qualifications. The firm values detailed information and expects a response time of approximately two weeks after submission.
In recent months, Westlake BioPartners has been actively engaged in the biotech sector, with notable blog posts highlighting equity financing and clinical developments from portfolio companies such as Recludix Pharma. The firm continues to monitor industry advancements and maintain a presence in discussions surrounding biotech innovation.
Westlake BioPartners remains committed to supporting its portfolio companies and fostering growth within the life sciences sector, reflecting their dedication to addressing significant patient needs through innovative solutions.
What investment criteria does Westlake BioPartners use?
Westlake BioPartners focuses on early-stage investments in the life sciences sector, particularly in biotech and healthcare. They look for companies that are developing new medicines and have a clear path to clinical and commercial impact.
How can founders pitch to Westlake BioPartners?
Founders can pitch their ideas by reaching out through the contact form on the Westlake BioPartners website. It is recommended to include a detailed overview of the business model, market opportunity, and team background in the pitch.
What makes Westlake BioPartners different from other investors?
Westlake BioPartners emphasizes a people-first approach, providing hands-on support and guidance throughout the company formation and growth process. Their concentrated portfolio allows for personalized attention to each company.
What is the geographic focus of Westlake BioPartners?
The firm primarily invests in North America, specifically within the United States, with a strong emphasis on the biotech ecosystem in Los Angeles.
What stages of investment does Westlake BioPartners engage in?
Westlake BioPartners invests at the pre-seed, seed, and Series A stages, targeting early-stage companies that are poised for growth in the life sciences sector.
What type of post-investment involvement does Westlake BioPartners have?
The firm actively engages with its portfolio companies, providing mentorship, operational support, and access to community resources to help them navigate the challenges of the biotech industry.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.